NO175430C - Analogifremgangsmåte for fremstilling av serotonin 5HT1A-agonister - Google Patents
Analogifremgangsmåte for fremstilling av serotonin 5HT1A-agonisterInfo
- Publication number
- NO175430C NO175430C NO913384A NO913384A NO175430C NO 175430 C NO175430 C NO 175430C NO 913384 A NO913384 A NO 913384A NO 913384 A NO913384 A NO 913384A NO 175430 C NO175430 C NO 175430C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- analogous procedure
- serotonin 5ht1a
- 5ht1a agonists
- agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57471090A | 1990-08-29 | 1990-08-29 | |
US07/735,700 US5189179A (en) | 1990-08-29 | 1991-07-30 | Serotonin 5ht1a agonists |
Publications (4)
Publication Number | Publication Date |
---|---|
NO913384D0 NO913384D0 (no) | 1991-08-28 |
NO913384L NO913384L (no) | 1992-03-02 |
NO175430B NO175430B (no) | 1994-07-04 |
NO175430C true NO175430C (no) | 1994-10-12 |
Family
ID=27076473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO913384A NO175430C (no) | 1990-08-29 | 1991-08-28 | Analogifremgangsmåte for fremstilling av serotonin 5HT1A-agonister |
Country Status (21)
Country | Link |
---|---|
US (3) | US5189179A (no) |
EP (1) | EP0478954B1 (no) |
JP (1) | JPH04270264A (no) |
KR (1) | KR920004345A (no) |
CN (1) | CN1030766C (no) |
AT (1) | ATE197040T1 (no) |
AU (1) | AU641535B2 (no) |
CA (1) | CA2049803A1 (no) |
DE (1) | DE69132450T2 (no) |
DK (1) | DK0478954T3 (no) |
ES (1) | ES2153346T3 (no) |
FI (1) | FI914065A (no) |
GR (1) | GR3035062T3 (no) |
HU (1) | HU208955B (no) |
IE (1) | IE913036A1 (no) |
IL (1) | IL99306A (no) |
NO (1) | NO175430C (no) |
NZ (1) | NZ239521A (no) |
PH (1) | PH30242A (no) |
PT (1) | PT98800B (no) |
TW (1) | TW200457B (no) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5189179A (en) * | 1990-08-29 | 1993-02-23 | Merrell Dow Pharmaceuticals Inc. | Serotonin 5ht1a agonists |
US5892112A (en) * | 1990-11-21 | 1999-04-06 | Glycomed Incorporated | Process for preparing synthetic matrix metalloprotease inhibitors |
USRE38506E1 (en) | 1991-10-04 | 2004-04-20 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and methods of use thereof |
US6406859B1 (en) | 1992-01-08 | 2002-06-18 | Synaptic Pharmaceutical Corporation | DNA encoding a 5-HT 1F receptor and uses thereof |
GB9211277D0 (en) | 1992-05-28 | 1992-07-15 | Glaxo Group Inc | Pharmaceutical compositions |
GB9304632D0 (en) * | 1993-03-06 | 1993-04-21 | Wyeth John & Brother Ltd | Amide derivatives |
FR2707294B1 (fr) * | 1993-07-06 | 1995-09-29 | Pf Medicament | Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine. |
US5478572A (en) * | 1994-09-06 | 1995-12-26 | Bristol-Myers Squibb Co. | Gepirone dosage form |
US6462048B2 (en) * | 1996-03-29 | 2002-10-08 | Pfizer Inc. | Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-HT1A- and/or 5-HT1D receptors |
US5872145A (en) * | 1996-08-16 | 1999-02-16 | Pozen, Inc. | Formulation of 5-HT agonist and NSAID for treatment of migraine |
US8022095B2 (en) * | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US6586458B1 (en) | 1996-08-16 | 2003-07-01 | Pozen Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
DK1068199T3 (da) * | 1998-04-08 | 2003-03-03 | Wyeth Corp | N-Aryloxyethyl-indolyl-alkylaminer til behandling af depression |
US6150533A (en) * | 1998-04-08 | 2000-11-21 | American Home Products Corp. | N-aryloxyethyl-indoly-alkylamines for the treatment of depression |
EP1070063A1 (en) * | 1998-04-08 | 2001-01-24 | American Home Products Corporation | Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists) |
US6121307A (en) * | 1998-04-08 | 2000-09-19 | American Home Products Corp. | N-aryloxyethyl-indoly-alkylamines for the treatment of depression |
WO1999051575A1 (en) * | 1998-04-08 | 1999-10-14 | American Home Products Corporation | N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents) |
US7588029B2 (en) * | 2000-03-21 | 2009-09-15 | Fisher & Paykel Healthcare Limited | Humidified gases delivery apparatus |
US7048934B2 (en) * | 2001-08-30 | 2006-05-23 | Stem Cell Therapeutics Inc. | Combined regulation of neural cell production |
JP4906231B2 (ja) | 2001-09-14 | 2012-03-28 | ステム セル セラピューティクス インコーポレイテッド | プロラクチン誘導性の神経幹細胞数の増加ならびにその治療用途 |
WO2003024471A2 (en) * | 2001-09-18 | 2003-03-27 | Stem Cell Therapeutics Inc. | Effect of growth hormone and igf-1 on neural stem cells and therapeutic application |
CA2492442A1 (en) * | 2002-07-31 | 2004-02-05 | Stem Cell Therapeutics Inc. | Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (pacap) |
CA2509023C (en) * | 2002-12-26 | 2011-05-24 | Pozen Inc. | Multilayer dosage forms containing nsaids and triptans |
WO2004110492A2 (en) * | 2003-06-06 | 2004-12-23 | Glaxo Group Limited | Composition comprising triptans and nsaids |
WO2005018541A2 (en) * | 2003-07-11 | 2005-03-03 | Pharmacia Corporation | Cox-2 inhibitor and serotonin modulator for treating cns damage |
US20070111932A1 (en) * | 2003-07-31 | 2007-05-17 | Stem Cell Therapeutics Inc. | Method of enhancing and/or inducing neuronal migration using erythropoietin |
CA2536340A1 (en) * | 2003-08-22 | 2005-03-03 | Pharmacia Corporation | Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin modulating agent for the treatment of neoplasia |
CN1325673C (zh) * | 2003-12-30 | 2007-07-11 | 上海交通大学 | 利用废旧紫铜生产无氧铜的装置 |
US7846898B2 (en) * | 2004-02-13 | 2010-12-07 | Stem Cell Therapeutics Corp. | Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis |
MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
AU2006249577A1 (en) | 2005-05-20 | 2006-11-30 | Janssen Pharmaceutica N.V. | Process for preparation of sulfamide derivatives |
KR20080074108A (ko) | 2005-09-27 | 2008-08-12 | 스템 셀 테라퓨틱스 코포레이션 | 프로락틴에 의해 조절되는 올리고덴드로사이트 전구체 세포증식 |
US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
US8492431B2 (en) | 2005-12-19 | 2013-07-23 | Janssen Pharmaceutica, N.V. | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
US20070191474A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine |
EP2004211A4 (en) * | 2006-03-17 | 2010-07-07 | Stem Cell Therapeutics Corp | DOSEERSCHEMATA FOR LH OR HCG AND EPO FOR THE TREATMENT OF NEUROLOGICAL DISEASES |
TW200812573A (en) | 2006-05-19 | 2008-03-16 | Janssen Pharmaceutica Nv | Co-therapy for the treatment of epilepsy and related disorders |
BRPI0915890A2 (pt) | 2008-06-23 | 2015-11-03 | Janssen Pharmaceutica Nv | forma cristalina de (2s)-(-)-n-(6-cloro-2,3-di-hidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida |
US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
CN111116451A (zh) * | 2020-01-16 | 2020-05-08 | 宁波大学 | 一种多取代色胺基苯甲酰胺类化合物及其制备方法和用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2725386A (en) * | 1953-02-13 | 1955-11-29 | Fond Emanuele Paterno | 2-(1, 4-benzodioxan) methyl derivatives of amino-lower fatty acid amides and preparation thereof |
FR2463765A1 (fr) * | 1979-08-17 | 1981-02-27 | Clin Midy | Nouveaux derives de l'indole actifs sur le systeme cardiovasculaire |
US4684739A (en) * | 1980-12-15 | 1987-08-04 | Mitsubishi Chemical Industries Limited | Alkylenedioxybenzene derivatives and acid addition salts thereof |
US4614807A (en) * | 1984-10-04 | 1986-09-30 | Eli Lilly And Company | 6,7-dihalomelatonins |
EP0252005B1 (de) * | 1986-06-26 | 1991-07-10 | Ciba-Geigy Ag | Hydrierte 1-Benzooxacycloalkyl-pyridincarbonsäureverbindungen |
DE3642497A1 (de) | 1986-12-12 | 1988-06-23 | Hoechst Ag | Substituierte aminopropionsaeureamide, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte |
US4956382A (en) * | 1987-02-07 | 1990-09-11 | Pfizer Inc. | Sulfonamide anti-arrhythmic agents |
US5189179A (en) * | 1990-08-29 | 1993-02-23 | Merrell Dow Pharmaceuticals Inc. | Serotonin 5ht1a agonists |
US5120758A (en) * | 1991-02-08 | 1992-06-09 | Ciba-Geigy Corporation | Certain benzodioxole, benzodioxane and benzodioxepin derivatives useful as 5-lipoxygenase inhibitors |
-
1991
- 1991-07-30 US US07/735,700 patent/US5189179A/en not_active Expired - Fee Related
- 1991-08-23 NZ NZ239521A patent/NZ239521A/xx unknown
- 1991-08-23 CA CA002049803A patent/CA2049803A1/en not_active Abandoned
- 1991-08-23 AU AU82664/91A patent/AU641535B2/en not_active Ceased
- 1991-08-26 IL IL9930691A patent/IL99306A/en unknown
- 1991-08-27 KR KR1019910014843A patent/KR920004345A/ko not_active Application Discontinuation
- 1991-08-28 DE DE69132450T patent/DE69132450T2/de not_active Expired - Fee Related
- 1991-08-28 ES ES91114456T patent/ES2153346T3/es not_active Expired - Lifetime
- 1991-08-28 NO NO913384A patent/NO175430C/no unknown
- 1991-08-28 IE IE303691A patent/IE913036A1/en not_active Application Discontinuation
- 1991-08-28 DK DK91114456T patent/DK0478954T3/da active
- 1991-08-28 FI FI914065A patent/FI914065A/fi not_active Application Discontinuation
- 1991-08-28 AT AT91114456T patent/ATE197040T1/de not_active IP Right Cessation
- 1991-08-28 PT PT98800A patent/PT98800B/pt not_active IP Right Cessation
- 1991-08-28 EP EP91114456A patent/EP0478954B1/en not_active Expired - Lifetime
- 1991-08-28 HU HU912810A patent/HU208955B/hu not_active IP Right Cessation
- 1991-08-29 PH PH43017A patent/PH30242A/en unknown
- 1991-08-29 TW TW080106873A patent/TW200457B/zh active
- 1991-08-29 CN CN91108614A patent/CN1030766C/zh not_active Expired - Fee Related
- 1991-08-29 JP JP3242328A patent/JPH04270264A/ja active Pending
-
1992
- 1992-10-16 US US07/962,434 patent/US5387604A/en not_active Expired - Fee Related
-
1994
- 1994-10-07 US US08/319,916 patent/US5559143A/en not_active Expired - Fee Related
-
2000
- 2000-12-13 GR GR20000402750T patent/GR3035062T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU641535B2 (en) | 1993-09-23 |
US5559143A (en) | 1996-09-24 |
DK0478954T3 (da) | 2001-01-08 |
CN1030766C (zh) | 1996-01-24 |
NO175430B (no) | 1994-07-04 |
CN1059717A (zh) | 1992-03-25 |
PH30242A (en) | 1997-02-05 |
PT98800A (pt) | 1992-08-31 |
HU208955B (en) | 1994-02-28 |
NO913384L (no) | 1992-03-02 |
JPH04270264A (ja) | 1992-09-25 |
GR3035062T3 (en) | 2001-03-30 |
CA2049803A1 (en) | 1992-03-01 |
NZ239521A (en) | 1993-07-27 |
TW200457B (no) | 1993-02-21 |
US5387604A (en) | 1995-02-07 |
ATE197040T1 (de) | 2000-11-15 |
AU8266491A (en) | 1992-03-05 |
DE69132450D1 (de) | 2000-11-23 |
EP0478954A1 (en) | 1992-04-08 |
US5189179A (en) | 1993-02-23 |
EP0478954B1 (en) | 2000-10-18 |
HUT59092A (en) | 1992-04-28 |
IL99306A0 (en) | 1992-07-15 |
DE69132450T2 (de) | 2001-05-03 |
FI914065A (fi) | 1992-03-01 |
IL99306A (en) | 1995-03-30 |
NO913384D0 (no) | 1991-08-28 |
FI914065A0 (fi) | 1991-08-28 |
KR920004345A (ko) | 1992-03-27 |
PT98800B (pt) | 1999-01-29 |
ES2153346T3 (es) | 2001-03-01 |
IE913036A1 (en) | 1992-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO175430C (no) | Analogifremgangsmåte for fremstilling av serotonin 5HT1A-agonister | |
NO914092D0 (no) | Fremgangsmaate for fremstilling av mercaptoacetylamidderivater | |
NO905608D0 (no) | Fremgangsmaate for fremstilling av a-nor-steroid-3-karboksylsyrederivater. | |
NO901392D0 (no) | Immunomodulerende azaspiraner. | |
ES510042A0 (es) | "un procedimiento de preparacion de nuevas carboxamidas heterociclicas". | |
DK0394905T3 (da) | Antagonister af excitatoriske aminosyrer | |
GR1000887B (el) | Νεα παραγωγα σπιροφουρανης. | |
FI894068A (fi) | Sulfonamider med tetrazolylrest, foerfarande foer deras tillverkning och laekemedel. | |
FI97388B (fi) | Menetelmä heterosyklisten NMDA-antagonistien valmistamiseksi | |
DK0457215T3 (da) | 3-deamino-4-desoxy-4-amino-8-fluoranthracycliner samt fremgangsmåder til fremstilling deraf | |
IL62226A (en) | ((substituted pyrimidinyl-ureido)-(2,3-dihydro-2-imino-4-thiazolyl))acetamido-cephalosporins,their preparation and pharmaceutical compositions containing them | |
ES2063157T3 (es) | Nuevos derivados del indol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
DE59008844D1 (de) | Benzylselenobenzamide von Aminopyridinen und Picolylaminen. | |
SE8201308D0 (sv) | Alkylendiaminderivat och forfarande for framstellning derav | |
ATE111919T1 (de) | Antibiotikum-derivat. | |
SE8701524L (sv) | Nya sulfonamider och deras framstaellningsfoerfarande | |
FR2645538B1 (fr) | Trichlorhydrate de (diethylamino-3 propyl)-amino-1 methyl-5 dipyrido (4,3-b) (3,4-f) indole | |
SE8802162L (sv) | Nya aminoacylater av glycerolacetal | |
YU47017B (sh) | Derivati indola, postupak za njihovo dobijanje i postupak za dobijanje farmaceutskih preparata koji ih sadrže | |
BR9706491A (pt) | Compostos de elipticina processo para a sua preparação e composições farmacêuticas contendo os mesmos |